PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: Principles and applications in veterinary pharmacology

Journal of Veterinary Pharmacology and Therapeutics

Volumn 27, Issue 6, 2004, Pages 491-502

  Lees, P ^a   Giraudel, J ^a,b   Landoni, M F ^c   Toutain, P L ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b CNRS   (France)

^c UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CARPROFEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FLUNIXIN; ISOENZYME; KETOPROFEN; MELOXICAM; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PROSTAGLANDIN SYNTHASE; TOLFENAMIC ACID; UNCLASSIFIED DRUG; VEDAPROFEN;

ALLOMETRY; BODY WEIGHT; CAT; CATTLE; CLINICAL FEATURE; COMPARTMENT MODEL; CONFERENCE PAPER; COW; DISEASE MARKER; DOG; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG SENSITIVITY; ENZYME INHIBITION; EX VIVO STUDY; GOAT; HORSE; IC 50; IN VITRO STUDY; IN VIVO STUDY; MODEL; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; SHEEP; SPECIES DIFFERENCE; STEREOCHEMISTRY; VETERINARY MEDICINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; MODELS, ANIMAL; MODELS, BIOLOGICAL; PHARMACOLOGY; VETERINARY DRUGS;

ANIMALIA; BOS TAURUS; CANIS FAMILIARIS; CAPRA HIRCUS; EQUUS CABALLUS; FELIS CATUS; OVIS ARIES;

EID: 10844269853     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00618.x     Document Type: Conference Paper

References (40)

1. Ariens, E.J. (1985) Stereochemistry. a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. European Journal of Clinical Pharmacology, 26, 663-668.
2. Arifah, K.A. & Lees, P. (2002) Pharmacodynamics and pharmacokinetics of phenylbutazone in calves. Journal of Veterinary Pharmacology and Therapeutics, 25, 299-309.
3. Arifah, A.K., Landoni, M.F. & Lees, P. (2003) Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat. Journal of Veterinary Pharmacology and Therapeutics, 26, 139-150.
4. Blain, H., Boileau, C., Lapicque, F., Nedelec, E., Loeuille, D., Guillalume, C., Gaucher, A., Jeandel, C., Netter, P. & Jouzeau, J.Y. (2002) Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. British Journal of Clinical Pharmacology, 53, 255-265.
5. Campbell, D.B. (1990) Stereoselectivity in clinical pharmacokinetics and drug development. European Journal of Drug Metabolism and Pharmacokinetics, 15, 109-125.
6. Cheng, Z., Nolan, A., Moneiro, A. & McKellar, Q. (2003) Enantioselective pharmacokinetic and cycloooxygenase inhibition of carprofen and carprofen enantiomers in sheep. Journal of Veterinary Pharmacology and Therapeutics, 26, 391-394.
7. Clarke, C.R. (1989) Tissue-chamber modeling systems - applications in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 12, 349-368.
8. Giraudel, J.M., Toutain, P.L. & Lees, P. (2003) Development and application of in vitro assays for the evaluation of inhibitors of constitutive and inducible cyclooxygenase. Journal of Veterinary Pharmacology and Therapeutics, 26(Suppl 1), 173-174.
9. Giraudel, J.M., Toutain, P.L. & Lees, P. (2004) Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and application for predicting the selectivity of NSAIDs in the cat. American Journal of Veterinary Research, in press.
10. Higgins, A.J. & Lees, P. (1983) Phenylbutazone inhibition of prostaglandin E2 production in equine acute inflammatory exudate. Veterinary Record, 113, 622-623.
11. Higgins, A.J., Lees, P. & Taylor, J.B. (1984) Influence of phenylbutazone on eicosanoid levels in equine inflammatory exudate. Cornell Veterinarian, 72, 198-207.
12. Landoni, M.F. & Lees, P. (1995a) Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling. Equine Veterinary Journal, 27, 247-256.
13. Landoni, M.F. & Lees, P. (1995b) Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves. Chirality, 7, 586-597.
14. Landoni, M.F. & Lees, P. (1996) Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in the horse. Journal of Veterinary Pharmacology and Therapeutics, 19, 466-474.
15. Landoni, M.F., Cunningham, F.M. & Lees, P. (1995a) Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling. Journal of Veterinary Pharmacology and Therapeutics, 18, 315-324.
16. Landoni, M.F., Cunningham, F.M. & Lees, P. (1995b) Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modelling. American Journal of Veterinary Research, 56, 786-793.
17. Landoni, M.F., Cunningham, F.M. & Lees, P. (1995c) Comparative pharmacodynamics of flunixin, ketoprofen and tolfenamic acid in calves. Veterinary Record, 137, 428-431.
18. Landoni, M.F., Cunningham, F.M. & Lees, P. (1996) Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. Research in Veterinary Science, 61, 26-32.
19. Landoni, M.F., Soraci, A.L., Delatour, A. & Lees, P. (1997) Enantioselective behaviour of drugs used in domestic animals: a review. Journal of Veterinary Pharmacology and Therapeutics, 20, 1-16.
20. Landoni, M.F., Comas, W., Mucci, N., Anglarilli, G., Bidal, D. & Lees, P. (1999) Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep. Journal of Veterinary Pharmacology and Therapeutics, 22, 349-359.
21. Lees, P., Taylor, J.B.O., Higgins, A.J. & Sharma, S.C. (1986) Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse. Journal of Veterinary Pharmacology and Therapeutics, 9, 204-212.
22. Lees, P., Taylor, J.B.O., Maitho, T.E., Millar, J.D. & Higgins, A.J. (1987) Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse. Cornell Veterinary, 77, 192-211.
23. Lees, P., Sedwick, A.D., Higgins, A.J., Pugh, K.E. & Busch, U. (1991) Pharmacodynamics and pharmacokinetics of miloxicam in the horse. British Veterinary Journal, 147, 97-108.
24. Lees, P., May, S.A., Hoeijmakers, M., Coert, A. & Rens, P.V. (1999) A pharmacodynamic and pharmacokinetic study with vedaprofen in an equine model of acute nonimmune inflammation. Journal of Veterinary Pharmacology and Therapeutics, 22, 96-106.
25. Lees, P., Landoni, M.F., Armstrong, S. & Frean, S. (2000). New insights into inflammation with particular reference to the role of COX enzymes. 8th EAVPT International Congress Proceedings. Journal of Veterinary Pharmacology and Therapeutics, 23(Suppl).
26. Lees, P., AliAbadi, F.S. & Landoni, M.F. (2002) Pharmacodynamics and enantioselective pharmacokinetics of racemic carprofen in the horse. Journal of Veterinary Pharmacology and Therapeutics, 25, 433-448.
27. Lees, P., Landoni, M.F., Giraudel, J. and Toutain, P.L. (2004) Pharmacodynamics and pharmacokinetics of nonsteroidal and-inflammatory drugs in species of veternary interest. Journal of Veterinary Pharmacology and Therapeutics, 27, 479-490.
28. Lepist, E.-I. & Jusko, W.J. (2004) Modeling and allometric scaling of S(+)-ketoprofen pharmacokinetics and pharmacodynamics: a retrospective analysis. Journal of Veterinary Pharmacology and Therapeutics, 27, 211-218.
29. Maitho, T.E., Lees, P. & Taylor, J.B. (1986) Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies. Journal of Veterinary Pharmacology and Therapeutics, 9, 26-39.
30. Sidhu, P., Shojaee AliAbadi, F., Andrews, M. & Lees, P. (2003) Tissue chamber model of acute inflammation in farm animal species. Research in Veterinary Science, 74, 67-77.
31. Soraci, A., Benoit, E., Jaussaud, P., Lees, P. & Delatour, P. (1995) Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses. American Journal of Veterinary Research, 56, 358-361.
32. Taylor, P.M., Delatour, P., Landoni, F.M., Deal, C., Pickett, C., Shojaee AliAbadi, F., Foot, R. & Lees, P. (1996) Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. Research in Veterinary Science, 60, 144-151.
33. Toutain P.L. (2002) Pharmacokinetics/pharmacodynamics integration in drug development and dosage regimen optimisation for veterinary medicine. AAPS Pharmaceutical Sciences 4, Article 38, URL: http://www.aapspharmsci.org/ scientificjournals/pharmsci/journal/ps040438.htm.
34. Toutain P.L. (2003) Pharmacokinetics/pharmacodynamics integration in dosage regimen optimisation for veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 26(Suppl 1), 1-8.
35. Toutain, P.L. & Cester, C.C. (2004) Dose titration responses to meloxicam in an equine carpitis model and pharmacokinetic/pharmacodynamic relationships. American Journal of Veterinary Research, in press.
36. Toutain, P.L. & Lees, P. (2004) Integration and modelling of pharmacokinetic and pharmacodynamic data to optimise dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 467-477.
37. Toutain, P.L., Autefage, A., Legrand, C. & Alvinerie, M. (1994) Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling. Journal of Veterinary Pharmacology and Therapeutics, 17, 459-469.
38. Toutain, P.L., Cester, C.C., Haak, T. & Metge, S. (2001a) Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog. Journal of Veterinary Pharmacology and Therapeutics, 24, 35-42.
39. Toutain, P.L., Cester, C.C., Haak, T. & Laroute, V. (2001b) A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog. Journal of Veterinary Pharmacology and Therapeutics, 24, 43-55.
40. Warner, T.D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J.A. & Vane, J.R. (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proceedings of the National Academy of Sciences, 96, 7563-7568.